AMTEC IIT: Phase 2 Multiarm Study in TNBC

NCT03801369 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

24

Enrollment

OTHER

Sponsor class

Stopped loss of funding

Conditions

Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Triple-Negative Breast Carcinoma

Interventions

PROCEDURE: Biopsy
DRUG: Capivasertib
DRUG: Ceralasertib
BIOLOGICAL: Durvalumab
DRUG: Olaparib
OTHER: Quality-of-Life Assessment
DRUG: Selumetinib

Sponsor

Gordon Mills, MD, PhD

Collaborators

[object Object]
[object Object]